<DOC>
	<DOCNO>NCT02167048</DOCNO>
	<brief_summary>This double-blind crossover study aim compare cognitive performance ( e.g. , work memory , selective attention cognitive flexibility ) child age 6-18 year diagnose ADHD combine type ( ADHD-C ) inattentive-type ( ADHD-IA ) currently &gt; 20 mg/day psychostimulants ( psychostimulants ) : ) current dose psychostimulants , vs. b ) lower-dose psychostimulants ( half current dose ) . The investigator hypothesize lower-dose psychostimulants result well cognitive performance moderate-to-high dos psychostimulants .</brief_summary>
	<brief_title>Low-dose vs. Normal-dose Psychostimulants Executive Functions Children With ADHD</brief_title>
	<detailed_description>Attention-deficit hyperactivity disorder ( ADHD ) neurodevelopmental disorder characterize attention deficit , hyperactivity , impulsive action appropriate individual ' age ( Barkley 1997 ) . These behavioural issue arise relatively early life , typically age 12 , continue persist adulthood many case ( Barkley 1997 ) . In school-aged child , ADHD associate low academic achievement , poor school performance , anxiety depression . Symptoms divide inattention ( e.g. , easily distract , difficulty focus &amp; complete task ) , hyperactivity ( e.g. , constantly motion , fidget , squirm , talk non-stop ) , impulsivity ( e.g. , difficult wait one 's turn , interrupt others ) . Three subtypes ADHD identify : predominantly inattentive ( ADHD-I ) , predominantly hyperactive-impulsive ( ADHD-H ) , combine type ( ADHD-C ) . Psychostimulants medium high dos act inhibit re-uptake dopamine dopamine transporter ( DAT ) , result increase dopamine concentration synapse . DAT abundant striatum , implicate hyperactivity impulsivity aspects ADHD . However , DAT sparse prefrontal cortex ( PFC ) , play critical role subserve executive function . Executive function ( EFs ; also call cognitive control self-regulation ) group process involve concentration , focused attention , self-control , cognitive flexibility , problem-solving , work memory ( ref : Diamond , 2013 ; Jacques &amp; Marcovitch , 2010 ) . Thus number high risk allele gene code dopamine transporter ( DAT1 ) associate hyperactivity ( depend striatum ) inattention EF deficit ( depend PFC ; ref : Jucaite et al. , 2005 ; Waldman et al. , 1998 . The action low dose psychostimulants show different , however . At low dos psychostimulants demonstrate act preferentially PFC , increase dopamine release ( ref : Berridge et al. , 2006 ; Schmeichel &amp; Berridge , 2013 ; Spencer et al , 2012 ) . Thus , moderate high dos psychostimulants ( dos often prescribed child youth ADHD ) probably improve PFC function EFs , bad , may actually impair cognitive function , leave patient feeling daze . Optimal dose psychostimulants child youth ADHD usually determine parent ' report improve behaviour , almost never performance cognitive measure . We propose look cognitive performance measure attention , work memory , planning , etc . child youths ADHD current dose psychostimulants half much ( order counterbalance across participant ) . Purpose/Objectives : This double-blind crossover study aim compare cognitive performance ( e.g. , work memory , selective attention cognitive flexibility ) child age 6-18 year diagnose ADHD combine type ( ADHD-C ) inattentive-type ( ADHD-IA ) currently &gt; 20 mg/day psychostimulants current dose psychostimulants lower-dose psychostimulants ( half current dose ) , order counterbalance across subject . To give u estimate order effect help u correct good performance 2nd session due simply take cognitive test twice ( note : test Version A B ) , also recruit healthy volunteer serve control group . This control group strictly intervention . Hypotheses : The investigator hypothesize lower-dose psychostimulants result well cognitive performance moderate-to-high dos psychostimulants .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Central Nervous System Stimulants</mesh_term>
	<criteria>Between chronological age 6 18 year Average aboveaverage IQ ( Parental report IQ 90 ; take word ) Meet DSMV criterion ADHD ( Combined type Inattentive type ) Currently treat respond oral Psychostimulants &gt; = 20 mg/day `` drug holiday '' Stable current Psychostimulant dose least 2 week Able communicate ( understand , speak , write ) English without aid interpreter Able execute simple manual response ( buttonpress ) require task The child parent give assent consent respectively child 's participation study Patients significant prior current medical condition could impact neuropsychological performance traumatic brain injury , hypoxia , unstable diabetes . Have medical condition could markedly increase sympathetic nervous system activity ( e.g . catecholaminesecreting neural tumor ) , take medication daily basis ( e.g . pseudoephedrine , oral steroid ) sympathomimetic activity . Note : regular onlabel use inhaler asthma ( e.g. , albuterol , steroidal ) permit Taking psychotropic medication onlabel Psychostimulants specifically prescribe treat ADHD Have major , uncorrected sensory impairment ( e.g . significant hearing impairment despite hear aid ) Lack sufficient English language skill perform task Are take medication specifically prescribe Psychostimulants may affect cognitive skill Have document history Dyslexia ( may skew result cognitive measure ) , Bipolar I II , psychosis , Depression , Autism Spectrum Disorders , Disruptive Mood Dysregulation Disorder Have past history severe adverse reaction lower Psychostiumlant dose Patient noncompliant Psychostimulants `` drug holiday '' Parental report IQ 90 ( take word )</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Attention Deficit Hyperactivity Disorders</keyword>
	<keyword>Executive Function</keyword>
	<keyword>Methylphenidate</keyword>
	<keyword>Psychostimulants</keyword>
	<keyword>Adolescent</keyword>
	<keyword>Child</keyword>
	<keyword>Working Memory</keyword>
	<keyword>Prefrontal Cortex</keyword>
	<keyword>Attention</keyword>
	<keyword>Cognitive Function</keyword>
	<keyword>Inhibition</keyword>
</DOC>